Editors' Picks

  • Sunday, November 29th, 2015

    Weighing The Week Ahead: Will The Fed Really Be Data Dependent?
    Jeff Miller SPY, QQQ, DIA 25 Comments
  • Saturday, November 28th, 2015

    Hidden Value And Takeover Potential In Aurico Metals
    Ben Kramer-Miller AGI, SAND, ARCTF 8 Comments
  • Concordia Healthcare - Getting Past A Series Of Unfortunate Events
    5i Research CXRX 9 Comments
  • Valuing Air Methods' 'Great Business And Crummy Stock'
    Tim Insko PHII, AIRM 4 Comments
  • Aercap: An Incredible Bargain Hiding In Plain Sight, 40-50% Upside (For Starters)
    Jeremy Raper AVOL, AYR, BA 72 Comments
  • Friday, November 27th, 2015

    Clovis: Execution Risk, Loss Of Credibility, & Regulatory Missteps Constrain Valuation
    Paul Nunzio DeSantis, Pharm.D AZN, CLVS 76 Comments
  • Investing For Retirement: A Different Strategy For The $7 Million Portfolio
    Colorado Wealth Management Fund ABM, AWR, CINF 208 Comments
  • Thanksgiving And Stock Ideas For A Happy Holidays And A Great New Year
    Dane Capital Management, LLC AGFS, CCL, CDRB 31 Comments
  • Black Friday: Midnight Madness At The Mall - Abercrombie, Hollister, American Eagle And Aeropostale Rock
    Jeff Sward AEO, ARO, EXPR
  • Where Can I Find Safe Income For Retirement? Part V
    Chris DeMuth Jr. AGC, AZSEY, BGB 209 Comments
  • A $1 Million Bet For Warren Buffett
    Chris DeMuth Jr. BIF, BRK.A, DHR 180 Comments
  • After Pandora's Steep Drop, An Acquisition Is Almost Inevitable
    Todd Hagopian P 13 Comments
  • Retirement FrontLine: Ex-Dividend Weekly Digest, Week Beginning November 30, 2016
    George Schneider ARCC, COP, CTL 47 Comments
  • Solithromycin From Cempra Is Positioning To Be The Treatment Of Choice For CABP
    Sirius Capital CNAT, CEMP 18 Comments
  • Premarket Biotech Digest: Clovis A Buy, Cellceutix Rallies, Pfizer's Avelumab Milestone
    Kanak Kanti De ADRO, AGN, AMGN 12 Comments
  • I Told You CorEnergy Was Poised To Profit, Now What?
    Brad Thomas CORR 133 Comments
  • Acacia Research's Inability To Explain Itself To Shareholders Has Created A Tremendous Opportunity
    Volte-Face Investments ACTG 31 Comments
  • Thursday, November 26th, 2015

    Real Industry, Inc.: Platform Value At Its Finest
    Peter Kaye RELY 22 Comments
  • Heron: A Compelling Short Thesis Before PDUFA
    Kanak Kanti De HRTX 12 Comments
  • Nutraceutical Is Not As Healthy As It Looks
    Timberwolf Equity Research TFM, AMZN, VSI 6 Comments